Becton, Dickinson and Company(BDX) is having a Dividend Yield of 1.62% with the Annual cash Dividend per share of $2.64. The last quarter cash dividend per share pay out was $0.73. Becton, Dickinson and Company has a 5 year average dividend yield of 1.91% and the stock has a Indicated annual dividend of $2.92. Becton, Dickinson and Company(BDX) formally announced its most recent dividend on January 24, 2017 with a Dividend per share of $0.73. The new indicated annual dividend based on announced dividend per share is $2.92. The dividend yield based on the forward looking indicated annual dividend is 1.62%. Becton, Dickinson and Company(BDX) has the most recent dividend payout ratio of 0.33 with a 5-year average payout ratio of 0.34. The 5 year historical dividend growth of Becton, Dickinson and Company(BDX) is at the rate of 10.17% while the R-Squared dividend growth is 0.96. If the value of R-Square is close to one, it indicates a perfect fit and the higher value conforms to the regression line while data close to zero indicates the opposite.
Becton, Dickinson and Company (NYSE:BDX) rose 0.29% or 0.53 points on Thursday and made its way into the gainers of the day. After trading began at $180.24 the stock was seen hitting $180.9 as a peak level and $178.92 as the lowest level. The stock ended up at $180.62. The daily volume was measured at 920,987 shares. The 52-week high of the share price is $181.755 and the 52-week low is $140.49. The company has a market cap of $38,440 million. Shares of Becton, Dickinson and Company rose by 1.58% in the last five trading days and 3.82% for the last 4 weeks. Becton, Dickinson and Company is up 8.78% in the last 3-month period. Year-to-Date the stock performance stands at 9.1%.
Currently the company Insiders own 1.4% of Becton, Dickinson and Company shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -29.16% . Institutional Investors own 82.3% of Becton, Dickinson and Company shares. During last six month period, the net percent change held by insiders has seen a change of -29.16%. Company has reported several Insider transactions to the SEC, on Feb 16, 2017, Jeffrey S Sherman (Sr. VP and General Counsel) sold 31,464 shares at 180.03 per share price.On Feb 15, 2017, Alexandre Conroy (Executive Vice President) sold 8,500 shares at 177.86 per share price.On Dec 16, 2016, John E Gallagher (VP, Corp Finance and Treasurer) sold 1,793 shares at 168.82 per share price.
Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.Becton Dickinson and Co was Downgraded by Raymond James to Outperform on Jan 5, 2017. Becton Dickinson and Co was Downgraded by JP Morgan to Neutral on Jan 3, 2017.
Becton Dickinson and Co Last issued its quarterly earnings results on Feb 2, 2017. The company reported $2.33 EPS for the quarter, beating the analyst consensus estimate by $ 0.21. Analyst had a consensus of $2.12. The company had revenue of $2922.00 million for the quarter, compared to analysts expectations of $2860.52 million. The companys revenue was down -2.1 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $1.96 EPS.
Becton, Dickinson and Co. is engaged principally in the manufacture and sale of a broad line of supplies, devices and systems used by health care professionals, medical research institutions and the general public. BDs operations consist of three worldwide business segments: Medical Systems, Biosciences, and Preanalytical Solutions.